Unleashing the Power of Gene Therapy
Reimagining Gene Therapy
Iragen Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. We aim to revolutionize how gene therapies are designed, developed and manufactured – improving speed to market and delivering significant reductions in the cost per dose. Using our computationally enabled platform for biocompatible, implemented kinetic effusion, BIKE™, and our high-efficiency manufacturing platform, we are advancing a deep and diversified pipeline of innovative gene therapies spanning rare and prevalent diseases in multiple therapeutic areas.
We believe that rationally engineered and manufactured gene therapies can transform the treatment of a broad universe of diseases – and we are prepared to lead this revolution in medicine.
Our Technology
BIKE™ is our proprietary platform for biompatible pharmacokinetic design and sequence modification. We are deploying BIKE to advance a pipeline of gene therapies addressing a range of diseases.
Manufacturing
Our proprietary high-efficiency manufacturing process integrates the latest advances in cell line technology. We plan to lead the modular production of gene therapies at larger scale and substantially lower cost than the industry status quo.